amylin glp-1 dual agonist Combined Amylin/GLP-1 pharmacotherapy to promote and sustain long-lasting weight loss Amylin receptor agonism enhances the

clunky patient portal Not available in 4 states (AR, LA, MS, NM) How to Get Started Fill out a 3-minute health intake form covering your medical history, current medications, and weight-loss goals Within 2448 hours, a board-certified physician reviews your submission and determines eligibility (no video call required for most patients) Labs may be ordered based on your health profile

Exercise and Movement Moving your body helps you keep muscle while losing fat

GLP-1 promotes -cell proliferation and glucose-induced insulin secretion in adults (1, 2)

[25] [66] The US Food and Drug Administration (FDA) approved semaglutide based on evidence from seven clinical trials of 4087 participants with type 2 diabetes

GLP-1 levels are elevated in patients post myocardial infarction